NCT04678206

Brief Summary

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 2b adaptive dose-finding study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

Trial Health

93
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
310

participants targeted

Target at P75+ for phase_2

Timeline
Completed

Started Dec 2020

Shorter than P25 for phase_2

Geographic Reach
7 countries

116 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 7, 2020

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

December 9, 2020

Completed
12 days until next milestone

First Posted

Study publicly available on registry

December 21, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 21, 2021

Completed
12 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 2, 2021

Completed
Last Updated

December 13, 2021

Status Verified

December 1, 2021

Enrollment Period

11 months

First QC Date

December 9, 2020

Last Update Submit

December 10, 2021

Conditions

Keywords

BLU-5937Refractory Chronic CoughP2X3 receptor antagonist

Outcome Measures

Primary Outcomes (1)

  • Change from baseline in the 24-hour cough frequency

    Assessed using an ambulatory cough monitor

    Week 4

Secondary Outcomes (5)

  • Percentage of Participants with a Reduction from Baseline in the 24-hour Cough Frequency by ≥ 30%, 50% and 70%

    Week 4

  • Change from Baseline in Leicester Cough Questionnaire (LCQ)

    Week 4

  • Change from baseline in cough severity

    Week 4

  • Incidence (% of subjects) of treatment-emergent adverse events (TEAEs)

    2 Weeks after the last study medication intake

  • Severity (mild, moderate, or severe) of treatment-emergent adverse events (TEAEs)

    2 Weeks after the last study medication intake

Study Arms (6)

BLU-5937 Dose A

EXPERIMENTAL

BLU-5937 oral dose A twice a day.

Drug: BLU-5937

BLU-5937 Dose B

EXPERIMENTAL

BLU-5937 oral dose B twice a day.

Drug: BLU-5937

BLU-5937 Dose C

EXPERIMENTAL

BLU-5937 oral dose C twice a day.

Drug: BLU-5937

Placebo

PLACEBO COMPARATOR

Matching Placebo for BLU-5937 oral dose twice a day.

Drug: Placebo

BLU-5937 Dose A (Population with baseline cough < 25 coughs/hour)

EXPERIMENTAL

BLU-5937 oral dose A twice a day.

Drug: BLU-5937

Placebo (Population with baseline cough < 25 coughs/hour)

PLACEBO COMPARATOR

Matching Placebo for BLU-5937 oral dose twice a day.

Drug: Placebo

Interventions

Oral administration of BLU-5937 Tablets

BLU-5937 Dose ABLU-5937 Dose A (Population with baseline cough < 25 coughs/hour)BLU-5937 Dose BBLU-5937 Dose C

Oral administration of matching placebo for BLU-5937 Tablets

PlaceboPlacebo (Population with baseline cough < 25 coughs/hour)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Capable of giving signed informed consent
  • Refractory chronic cough (including unexplained chronic cough) for at least one year
  • Women of child-bearing potential must use a highly effective contraception method during the study and for at least 14 days after the last dose

You may not qualify if:

  • Current smoker/vaper (all forms of smoking and inhaled substances, including , cannabis/tobacco smoke and nicotine vapors) or individuals who have given up smoking within the past 6 months, or those with \>20 pack-year smoking history
  • Diagnosis of Chronic Obstructive Pulmonary Disease (COPD), bronchiectasis, idiopathic pulmonary fibrosis or uncontrolled asthma
  • Respiratory tract infection within 4 weeks before screening
  • Laboratory confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection at screening
  • History of malignancy in the last 5 years
  • History of alcohol or drug abuse within the last 3 years
  • Has a positive serologic test for human immunodeficiency virus (HIV), hepatitis B virus surface antigen, or hepatitis C virus.
  • Previous participation in a BLU-5937 trial

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (116)

Phoenix Medical Research Inc

Peoria, Arizona, 85381, United States

Location

Little Rock Allergy and Asthma Clinical Research Center

Little Rock, Arkansas, 21237, United States

Location

Southern California Institute For Respiratory Diseases, Inc

Los Angeles, California, 90048, United States

Location

Allergy and Asthma Associates of Southern California

Mission Viejo, California, 92691, United States

Location

California Medical Research Associates, Inc.

Northridge, California, 91324, United States

Location

Allergy Associates Medical Group Inc.

San Diego, California, 92120, United States

Location

Allergy and Asthma Associates of Santa Clara Valley Research Center

San Jose, California, 95117, United States

Location

Colorado Allergy and Asthma Centers

Denver, Colorado, 80230, United States

Location

St. Francis Medical Institute

Clearwater, Florida, 33765, United States

Location

Floridian Clinical Research

Hialeah, Florida, 33016, United States

Location

Sweet Hope Research Specialty, Inc.

Hialeah, Florida, 33016, United States

Location

Sher Allergy Specialist/Center for Cough

Largo, Florida, 33778, United States

Location

Medical Research of Central Florida

Leesburg, Florida, 34748, United States

Location

ProCare Clinical Research

Miami Lakes, Florida, 33014, United States

Location

Central Florida Pulmonary Group PA

Orlando, Florida, 32803, United States

Location

Lenus Research & Medical Group

Sweetwater, Florida, 33172, United States

Location

IACT Health - Columbus

Columbus, Georgia, 31904, United States

Location

IACT Health - Lawrenceville

Lawrenceville, Georgia, 30046, United States

Location

IACT Health - Rincon

Rincon, Georgia, 31326, United States

Location

Sneeze Wheeze and Itch Associates LLC

Normal, Illinois, 61761, United States

Location

AES - Synexus Clinical Research US, Inc. - Evansville

Evansville, Indiana, 47714, United States

Location

Abraham Research PLLC

Fort Mitchell, Kentucky, 41017, United States

Location

Infinity Medical Research Inc

North Dartmouth, Massachusetts, 02747, United States

Location

Minnesota Lung Center

Edina, Minnesota, 55435, United States

Location

Mayo Clinic

Rochester, Minnesota, 55905, United States

Location

Minnesota Lung Center

Woodbury, Minnesota, 55125, United States

Location

The Lung Research Center, LLC

Chesterfield, Missouri, 63017, United States

Location

University of Missouri, ENT and Allergy Center of Missouri

Columbia, Missouri, 65201, United States

Location

The Clinical Research Center LLC

St Louis, Missouri, 63141, United States

Location

Montana Medical Research

Missoula, Montana, 59808, United States

Location

Creighton University Medical Center

Omaha, Nebraska, 68124, United States

Location

Atlantic Respiratory Institute

Summit, New Jersey, 07901, United States

Location

Albuquerque Clinical Trials Inc

Albuquerque, New Mexico, 87102, United States

Location

CHEAR Center LLC

The Bronx, New York, 10455, United States

Location

American Health Research Inc

Charlotte, North Carolina, 28277, United States

Location

Clinical Research of Gastonia

Gastonia, North Carolina, 28054, United States

Location

Southeastern Research Center

Winston-Salem, North Carolina, 27103, United States

Location

Bernstein Clinical Research Center Inc

Cincinnati, Ohio, 45231, United States

Location

The Cleveland Clinic Foundation

Cleveland, Ohio, 44195, United States

Location

Remington Davis Inc

Columbus, Ohio, 43215, United States

Location

Vital Prospects Clinical Research Institute PC

Tulsa, Oklahoma, 74136, United States

Location

Clinical Research Associates Of Central Pa

Altoona, Pennsylvania, 16601, United States

Location

Synexus Clinical Research US, Inc.

Anderson, South Carolina, 29621, United States

Location

National Allergy and Asthma Research

Charleston, South Carolina, 29420, United States

Location

Clinical Research of Rock Hill

Rock Hill, South Carolina, 29732, United States

Location

Clinical Trials Center of Middle Tennessee

Franklin, Tennessee, 37067, United States

Location

Pharmaceutical Research & Consulting Inc

Dallas, Texas, 75231, United States

Location

El Paso Pulmonary Association

El Paso, Texas, 79902, United States

Location

Village Research, LLC

Houston, Texas, 77084, United States

Location

Metroplex Pulmonary and Sleep Medicine Center

McKinney, Texas, 75069, United States

Location

Diagnostics Research Group

San Antonio, Texas, 78229, United States

Location

Sherman Clinical Research

Sherman, Texas, 75092, United States

Location

Allergy Asthma Research Institute

Waco, Texas, 76712, United States

Location

Intermountain Clinical Research

Draper, Utah, 84020, United States

Location

TPMG Lung & Sleep Specialist

Williamsburg, Virginia, 23188, United States

Location

McMaster University Medical Centre

Hamilton, Ontario, L8N 3Z5, Canada

Location

Diex Recherche - Québec

Québec, Quebec, G1N 4V3, Canada

Location

Clinique Spécialisée en Allergie de la Capitale

Québec, Quebec, G1V 4W2, Canada

Location

Inspiration Research Limited

Toronto, Quebec, M5T 3A9, Canada

Location

C I C Maurice Inc

Trois-Rivières, Quebec, G8T 7A1, Canada

Location

Diex Recherche - Victoriaville

Victoriaville, Quebec, G6P 6P6, Canada

Location

MUDr. I. Cierná Peterová s.r.o.

Brandýs nad Labem-Stará Boleslav, Central Bohemia, 250 01, Czechia

Location

Pneumologie Varnsdorf S.r.o.

Nový Bor, Liberec, 473 01, Czechia

Location

Plicní ambulance Rokycany s.r.o.

Rokycany, Plzeň, 33701, Czechia

Location

Synexus Czech s.r.o.

Prague, Prague, 120 00, Czechia

Location

MediTrial s.r.o.

Jindřichův Hradec, South Bohemia, 377 01, Czechia

Location

MUDr. Jaroslav Mares - odborny lekar pro obor tuberkulosa a respiracni nemoci

Strakonice, South Bohemia, 386 01, Czechia

Location

Plicni stredisko Teplice s.r.o.

Teplice, Ústí Nad Labem, 415 01, Czechia

Location

Thoraxklinik-Heidelberg gGmbH

Heidelberg, Baden-Wurttemberg, 69126, Germany

Location

Synexus Frankfurt Research Centre

Frankfurt am Main, Hesse, 60313, Germany

Location

IKF Pneumologie

Frankfurt am Main, Hesse, 60596, Germany

Location

Zentrum für ambulante pneumologische Forschung Marburg GbR

Marburg, Hesse, 35037, Germany

Location

Ballenberger. Freytag. Wenisch - Institut fuer klinische Forschung GmbH

Neu-Isenburg, Hesse, 63263, Germany

Location

Kfns Klinische Forschung Schwerin

Schwerin, Mecklenburg-Vorpommern, 19055, Germany

Location

Universitätsklinikum Bonn

Bonn, North Rhine-Westphalia, 53127, Germany

Location

Klinische Forschung Dresden GmbH (KFGN)

Dresden, Saxony, 01069, Germany

Location

Synexus Leipzig Research Centre

Leipzig, Saxony, 04103, Germany

Location

Ärztezentrum Axel Springer Passage

Berlin, 10969, Germany

Location

Da Vinci Maganklinika

Pécs, Baranya, 7635, Hungary

Location

Synexus Gyula - Magyarország Egészségügyi Szolgáltató Kft

Gyula, Bekes County, 5700, Hungary

Location

Dr. Kenessey Albert Korhaz-Rendelointezet

Balassagyarmat, Nógrád megye, 2660, Hungary

Location

Szent Borbála Kórház

Tatabánya, Nógrád megye, 2800, Hungary

Location

Synexus Zalaegerszeg Magyarország Egészségügyi Kft

Zalaegerszeg, Zala County, 8900, Hungary

Location

Synexus Budapest - Magyarország Egészségügyi Szolgáltató Kft

Budapest, 1036, Hungary

Location

Osrodek Badan Klinicznych CLINSANTE S.C. Ewa Galczak-Nowak Malgorzata Trzaska

Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 31-826, Poland

Location

Medical Center Kermed

Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-231, Poland

Location

Centrum Medyczne Bydgoszcz - PRATIA

Bydgoszcz, Kuyavian-Pomeranian Voivodeship, 85-796, Poland

Location

Alergo-Med Specjalistyczna Przychodnia Lekarska Sp. z.o.o

Tarnów, Lesser Poland Voivodeship, 33-100, Poland

Location

KLIMED

Bychawa, Lublin Voivodeship, 23-100, Poland

Location

Clinical Best Solutions -Lublin

Lublin, Lublin Voivodeship, 20-078, Poland

Location

Centrum Alergologii Specjalistyczna Przychodnia Alergologiczna

Lublin, Lublin Voivodeship, 20-552, Poland

Location

Centrum Medyczne Warszawa - PRATIA

Warsaw, Masovian Voivodeship, 01-869, Poland

Location

Prywatny Gabinet Internistyczno-Alergologiczny

Bialystok, Podlaskie Voivodeship, 15-010, Poland

Location

Synexus Polska Sp. z o.o. Oddzial w Gdansku

Gdansk, Pomeranian Voivodeship, 80-382, Poland

Location

Synexus Polska Sp. z o.o. Oddzial w Czestochowie

Częstochowa, Silesian Voivodeship, 42-202, Poland

Location

Centrum Medyczne Wos i Piwowarczyk

Kraków, Łódź Voivodeship, 31-572, Poland

Location

Synexus Polska Sp. Z o.o Oddzial w Lodzi

Lodz, Łódź Voivodeship, 90-127, Poland

Location

Ostrowieckie Centrum Medyczne Spólka Cywilna Anna Olech-Cudzik, Krzysztof Cudzik

Ostrowiec Świętokrzyski, Świętokrzyskie Voivodeship, 27-400, Poland

Location

Synexus Midlands Clinical Research Centre

Birmingham, England, B15 2SQ, United Kingdom

Location

West Walk Surgery

Bristol, England, BS37 4AX, United Kingdom

Location

MeDiNova Northamptonshire Quality Research Site

Corby, England, NN18 9EZ, United Kingdom

Location

Castle Hill Hospital

Cottingham, England, HU16 5JQ, United Kingdom

Location

MeDiNova Warwickshire Quality Research Site

Kenilworth, England, CV8 1JD, United Kingdom

Location

Kings College Hospital

London, England, SE5 9RS, United Kingdom

Location

Royal Brompton Hospital

London, England, SW3 6NP, United Kingdom

Location

NW Consortium Manchester

Manchester, England, M15 6SX, United Kingdom

Location

Wythenshawe Hospital - PPDS

Manchester, England, M23 9LT, United Kingdom

Location

MeDiNova North London Quality Research Site

Middlesex, England, HA6 2RN, United Kingdom

Location

North Tyneside General Hospital

North Shields, England, NE29 8NH, United Kingdom

Location

MeDiNova East London Quality Research Site

Romford, England, RM1 3PJ, United Kingdom

Location

MeDiNova Yorkshire Quality Research Site

Shipley, England, BD18 3SA, United Kingdom

Location

MeDiNova South London Quality Research Site

Sidcup, England, DA14 6LT, United Kingdom

Location

MeDiNova West London Quality Research Site

Wokingham, England, RG40 1XS, United Kingdom

Location

Ormeau Clinical Trials Limited

Belfast, Northern Ireland, BT7 2EB, United Kingdom

Location

Belfast City Hospital

Belfast, Northern Ireland, BT9 7AB, United Kingdom

Location

AES - Synexus Scotland Clinical Research Centre

Glasgow, Scotland, G20 0SP, United Kingdom

Location

Related Publications (1)

  • Smith JA, Birring SS, Blaiss MS, McGarvey L, Morice AH, Sher M, Carroll KJ, Garin M, Lanouette S, Shaw J, Yang R, Bonuccelli CM. Camlipixant in Refractory Chronic Cough: A Phase 2b, Randomized, Placebo-controlled Trial (SOOTHE). Am J Respir Crit Care Med. 2025 Jun;211(6):1038-1048. doi: 10.1164/rccm.202409-1752OC.

MeSH Terms

Conditions

Chronic Cough

Interventions

BLU-5937

Condition Hierarchy (Ancestors)

CoughRespiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 9, 2020

First Posted

December 21, 2020

Study Start

December 7, 2020

Primary Completion

October 21, 2021

Study Completion

November 2, 2021

Last Updated

December 13, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations